We performed a meta-analysis of over 30 case-control studies of association between schizophrenia and a bi-allelic, Bal I polymorphism in exon 1 of the dopamine D3 receptor gene. We observed a significant excess of both forms of homozygote in patients (P = 0.0009, odds ratio (OR) = 1.21, 95% Confidence Interval (CI) = 1.07-1.35) in the combined sample of 5351 individuals. No significant heterogeneity was detected between samples and the effects did not appear to be the product of publishing bias. In addition we undertook an independent, familybased association study of this polymorphism in 57 parent/proband trios, taken from unrelated European multiplex families segregating schizophrenia. A transmission disequilibrium test (TDT) showed a significant excess of homozygotes in schizophrenic patients (P = 0.004, odds ratio (OR) = 2.7, 95% CI = 1.35-5.86). Although no significant allelic association was observed, a significant association was detected with the 1-1 genotype alone (P = 0.02, OR = 2.32, 95% CI = 1.13-4.99). In addition when the results of the family-based association study were included in the meta-analysis, the homozygosity effect increased in significance (P = 0.0002, OR = 1.23, 95% CI = 1.09-1.38). The results of the meta-analysis and family-based association study provide independent support for a relationship between schizophrenia and homozygosity at the Bal I polymorphism of the D3 receptor gene, or between a locus in linkage disequilibrium with it.
Introduction
There is compelling evidence for a substantial genetic contribution to the aetiology of schizophrenia. 1, 2 However, the disorder appears genetically complex and is unlikely to be due to a single major gene. [3] [4] [5] Alternative genetic models stress the action of genes of minor effect, co-acting or inter-acting with other minor genes 6, 7 or with a gene or genes of major effect. 8 Such genetic complexity and the consequent uncertainties surrounding the mode of transmission at any given locus, may impede traditional lod score linkage approaches. An additional, complementary approach to positional cloning, is offered by studies of genetic association of candidate genes. 9, 10 Disturbances in dopamine neurotransmission and dopamine receptors have long been postulated to play a key role in schizophrenia. 11 Originally, dopamine was thought to affect its target cells through the interaction of two receptor subtypes, known as D1 and D2, which were shown to differ in pharmacological specificity. 12 It also appeared that the therapeutic effects of anti-psychotic drugs were related to their high affinity for the D2 receptor. However, more recently, additional dopamine receptors have been found (eg, D3, D4 and D5). [13] [14] [15] Expression of the D3 receptor gene appears to be concentrated in the limbic system, which has been implicated in schizophrenia by both neuropathological and neuroimaging studies. 16 Animal studies have also shown that expression of the D3 gene in rat brains, is up-regulated both by the administration of typical (eg haloperidol) and atypical neuroleptics (eg clozapine) 17 whereas up-regulation of D1 and D2 receptor gene expression when observed, occurs only in response to typical neuroleptics. 18, 19 These findings suggest that a plausible case can be made for the involvement of the D3 receptor in the pathogenesis of schizophrenia. Recently, Accili and colleagues 20 successfully generated mice lacking in functional D3 receptors. They found that binding of the dopamine antagonist [ 125 I]iodosulprid to D3 receptors was absent in mice homozygous for the mutation and greatly reduced in heterozygous mice. Their behavioural analysis of the mutant mice demonstrated that this mutation was associated with hyperactivity in an exploratory test, thus indicating that D3 receptors play an inhibitory role in the control of certain behaviours.
The human D3 receptor gene was localised to chromosome 3q13.3 by in situ hybridisation. 21 It contains a polymorphic site in the first exon that gives rise to a serine to glycine substitution in the N-terminal extracellular domain. This creates a BalI restriction enzyme site. 22 Recently, Lundstrom and Turpin 23 found a significantly higher dopamine-binding affinity for the glycine-glycine (BalI,2-2) homozygote compared to the heterozygote and serine-serine homozygote. They also observed that both the glycine-glycine homozygote and the heterozygote showed significantly higher binding activity for GR99841 compared to the serine-serine homozygote (1-1, BalI). These findings are important as they support the existence of functional differences between D3 receptor genotypes.
Although no evidence of genetic linkage has been found between schizophrenia and this polymorphism, 24 groups in Cardiff, UK, and Rouffach, France, independently found an association between homozygosity and schizophrenia. 25 This finding has been replicated in Cardiff, 26 but with a reduced size and level of statistical significance in the sample as a whole (P = 0.05, one-tailed test). However, more detailed analysis suggested that excess homozygosity is most pronounced in those patients with a family history of schizophrenia (especially those from multiply affected families), in patients with a good response to neuroleptics and in males. Two further studies found excess homozygosity in two of these sub-groups. Nimgaonkar and colleagues 27 found a strong effect in those patients with a family history of schizophrenia and Jonssen et al 28 found increased levels of homozygosity in schizophrenics with a good response to neuroleptics. Nimgaonkar et al 29 also found a significant excess of allele 1 homozygotes in a population of Afro-American patients. In contrast, others have reported negative findings in unselected samples. 28, [30] [31] [32] Recently Hawi and colleagues 33 presented a critique of the studies showing a D3 association with schizophrenia and concluded that, in their opinion, there was no effect. However, it must be noted that the decision to discount a study or studies, because an aspect of it can be criticised, may be to some extent subjective. A more objective and comprehensive approach may be of use in assessing the significance of these findings.
If these inconsistencies are not due to chance then we must consider three possibilities. First, the BalI polymorphism or a DNA variation in linkage disequilibrium with it, may in fact have a small effect upon susceptibility to schizophrenia and the failures to replicate stem from a lack of statistical power. The second possibility is that heterogeneity exists within and between the samples, such that excess homozygosity may be restricted to, or be stronger in, a specific subgroup of patients. Third, the disparate findings may reflect imperfect matching between patients and controls leading to stratification. This could either produce a false positive finding or obscure a true positive result. We addressed these possibilities by performing a comprehensive meta-analysis of all known case-control studies of association and family-based association studies focusing on a sub-group of patients in which previous studies predict a strong homozygosity effect. The meta-analysis was chosen to test for heterogeneity between samples and produce an estimate of effect size. No selection criteria were applied as the authors could not justify excluding any particular study, without risk of introducing bias.
Existing data indicate that the presence of a family history of schizophrenia is a factor strongly associated with excess homozygosity. 26, 27 This observation would fit with complex models of aetiology for schizophrenia 3, 34 which predict that those with a high familial loading are more likely to possess genetic risk factors. The present family-based study focuses upon this finding and attempts to demonstrate excess homozygosity in a sample of schizophrenics with at least one other affected first-degree relative. We also used an experimental design that mitigates against the possible confounding effects of population stratification. Although this is an important factor in all association studies it is of particular relevance to studies which involve pooled data from different countries and populations, as is the case here, as allele frequencies can vary between populations. If the cases and controls are sampled from different populations (stratification) then the observed sample differences could be misinterpreted as an association with the disease in question. To overcome this we assessed the transmission disequilibrium of the genotype passed down to each affected offspring conditional on their parental genotypes. 35 Similar family-based association studies have proved particularly useful in detecting genes involved in other complex disorders and when using a candidate gene association approach.
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Material and methods
Meta-analysis
Over 30 case-control studies were included in the meta-analysis of the D3 receptor gene and schizophrenia (see Table 1 ). These studies were ascertained from a med-line literature search and personal communications with individual researchers in this field. All studies used comparable methods and designs. The total sample comprised 2722 cases with schizophrenia and 2629 controls. It is important to note that the samples for the meta-analysis and the family-based TDT study did not overlap. The Woolf method 37 was used to test for association. This method of analysis allows data from different populations to be combined and provides a means of testing for heterogeneity. This sample has over 90% power to detect a small effect (w = 0.1, P = 0.01, d.f. = 1). 38 The 2 statistic was also used to test for Hardy-Weinberg equilibrium in all control populations included in the meta-analysis. Finally, a funnel plot analysis of the case-control studies was performed to test for publication bias.
Transmission disequilibrium study
The subjects were 57 patients with DSM-III-R schizophrenia/schizoaffective (4) disorder (35 males and 22 females) from whose parents, DNA was available. Each trio of affected individual and parents, was taken from a separate multiplex family used for linkage analysis in centres throughout Europe. Only one trio was chosen, randomly, from within each family, blind to D3 genotype. Trios were sampled from nine different European Centres. There was no overlap between this and other samples in which D3 genotypic associations had been studied previously. All patients were interviewed using a standard diagnostic interview (SADS-LA, PSE 9 or SCAN). The OPCRIT system 39 was used to achieve a diagnosis (OPCRIT diagnoses were not obtainable on five patients who were diagnosed by clinical consensus). Good inter-rater reliability between centres had already been established. 40 All subjects gave informed consent to participate in molecular genetic research.
High molecular weight genomic DNA was extracted from whole blood or transformed lymphoblasts according to routine procedures. The BalI polymorphism was typed by restriction enzyme digestion after amplification of genomic DNA with polymerase chain reaction (PCR). The PCR products were digested with BalI before agarose gel electrophoresis and staining with ethidium bromide. The undigested PCR product was 462 bp in size. Digestion produced constant bands of 111 and 47 bp. The presence of a further 304-bp band denoted a 1-1 homozygote, bands at 206 and 98 bp, a 2-2 homozygote and bands at 304, 206 and 98 bp, a heterozygote. Genotyping was either carried out by the collaborating centre or by the co-ordinating centre at Cardiff.
The Transmission Disequilibrium Test (TDT 40, 41 ) was employed to test for allelic association. TDT analysis tests for a distortion in allelic transmission from parental matings (ie, informative mating) capable of transmitting more than one allele and from which expected transmission ratios could be calculated. Similarly, our test of genotypic transmission disequilibrium only used genotype counts from informative matings from which likelihood ratios can be calculated. For example, in the case of homozygotes (1- 37 to test for heterogeneity using transmitted and non-transmitted genotypes between participating centres. Table 1 shows the results of the meta-analysis of association between schizophrenia and D3 homozygosity. A significant excess of homozygotes (1-1 and 2-2 genotypes) was observed in the sample as a whole (P = 0.0009, OR = 1.21, 95% Confidence Interval (CI) = 1.07-1.35) with no evidence of heterogeneity between centres (P = 0.33). This effect remains significant when data from the first published study 25 were removed from the analysis (P = 0.005). No evidence of an allelic association was observed (P = 0.16).
Results
Meta-analysis
On a post hoc basis we explored the pattern of genotypic effect in these samples. We observed no difference between 1-1 and 2-2 genotype distributions in cases and controls (P = 0.99). We did observe a significant excess of the 1-1 genotype compared to heterozygotes alone, (P = 0.0008, OR = 1.23, CI = 1.09-1.38), and of the 2-2 genotype compared to heterozygotes (P = 0.03, OR = 1.24, CI = 1.02-1.5). No evidence of heterogeneity was observed between centres in any of the tested effects (1-1/1-2: P = 0.12, 2-2/1-2: P = 0.19). All control samples included in the meta-analysis were in Hardy-Weinberg equilibrium (data not shown). Figure 1 shows a funnel plot of the sample size and effect size (odds ratio) of the published studies (excluding abstracts) included in the meta-analysis. The inverted funnel shape of the plot indicates an absence of publication bias, as it shows no evidence of a failure to publish small studies with low odds ratios. Table 2 shows the distribution of patient genotypes as a function of parental mating genotypes. A transmission disequilibrium analysis showed significant distortion of homozygote transmission ( As the study involved pooling data from a number of European Centres, a heterogeneity analysis was applied. Table 3 Finally, when these results (see Table 3 ) were included in the meta-analysis the homozygosity effect increased in significance (P = 0.0002, OR = 1.23, 95% CI = 1.09-1.38). Table 2 The frequency of D3 BalI patient genotypes shown as a function of parental genotypes
Transmission disequilibrium
Patient genotype
Parental genotypes
Parental matings informative for homozygosity.
Discussion
A meta-analysis of over 30 case-control studies showed a significant association between schizophrenia and both forms of homozygote of the bi-allelic, BalI polymorphism of the dopamine D3 receptor gene. We also observed an excess of 1-1 homozygotes alone. Using post-hoc comparisons we did not detect a difference between allele 1 and allele 2 homozygotes in the combined sample. No significant heterogeneity was detected between studies and the homozygosity effect appeared not to have been the product of publishing bias, although it is accepted that a funnel plot provides an indication of publishing bias and is not a precise test.
In addition we found significant association between schizophrenia and both homozygosity and the 1-1 genotype at the D3 receptor gene, in a sample of independent trios taken from separate multiplex families across Europe. This supports previous findings 25, 26 and specifically supports the observation that the excess of homozygosity was especially strong in multiplex families segregating psychosis. 26 Our use of the family trios method together with samples taken from a variety of independent, geographically dispersed centres, makes it highly unlikely that these results were due to stratification or inbreeding. Further evidence that inbreeding is unlikely to underlie the observed excess in homozygosity has been presented in previous casecontrol studies. 26 These show no evidence of HardyWeinberg disequilibrium in other unlinked polymorphisms in the same samples which originally displayed excess D3 homozygosity. Our previous work also shows that excess homozygosity is not a consequence of a mutation in the DNA sequence to which one of the PCR primers binds, since the same findings were obtained when a second set of primers was used for PCR. 26 Our findings are also unlikely to reflect incomplete restriction enzyme digestion since this would not result in an excess of allele 2. Furthermore the presence of two non-polymorphic BalI sites within the PCR product served as internal controls for digestion. Another possibility is that our findings reflect the presence of a micro-deletion resulting in haplo-insufficiency of D3 in schizophrenia. However, no allele loss was seen in this or previous family studies. 26 We recognise that excess homozygosity in a disease population is not a typical finding in genetic associ- ation studies, although precedents do exist. 61 One possible explanation is that the presence of two different molecular forms of the receptor results in an increased ability to respond adaptively to variations in the environment, occurring either during neural development or in adult life. 25 Indeed the present findings could be seen as an example of heterosis, with heterozygosity at D3 conferring protection against schizophrenia. Susceptibility to Creutzfeldt-Jakob disease also shows an effect of homozygosity for an amino acid substitution in the prion protein gene (PRNP). 62 This methionine to valine change confers different relative risks, such that: Met/Met:Val/Val:Met/Val combinations result in 11:4:1 risk ratios, respectively.
Recently, Lundstrom and Turpin 23 found that the 2-2 genotype showed significantly higher dopamine binding affinity than the 1-2 and 1-1 genotypes. They also observed a higher binding activity for GR99841 in the 2-2 and 1-2 genotypes compared to the 1-1 genotype. This indicates that this polymorphism may have functional significance although the direct mode of action is as yet unknown. In fact, this polymorphism does not lie within those parts of the protein usually involved in signal transduction or ligand-binding. However, it may change the way in which the protein is inserted into the membrane. Alternatively, it might not itself be of functional significance but be in linkage disequilibrium with another genetic variant that is. This could be located elsewhere in the coding sequence of D3, in the regulatory region of the gene or even in a gene close by.
Finally, although no significant heterogeneity was detected between centres, the fact that some centres showed no evidence of effect should be addressed. A number of possibilities exists. If the effect is small as suggested by these data, then sampling differences could explain these inconsistencies. Alternatively, if we have detected linkage disequilibrium with another locus, then individual population samples may display different levels of disequilibrium. It is also possible although less likely, that different populations may be affected by different risk factors. In conclusion, our findings suggest that the balance of evidence favours an association between schizophrenia and homozygosity of the Ser 9 Gly polymorphism in the dopamine D3 receptor gene. This might reflect a direct relationship with the BalI polymorphism or be the result of linkage disequilibrium with another locus close by. However, an overall relative risk of between 1.21 and 2.7 in these samples suggests that the magnitude of the effect may well be small.
